A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

B.C. Kuenen; P.O. Witteveen; R. Ruijter; G. Giaccone; A. Dontabhaktuni; F. Fox; T. Katz; H. Youssoufian; J.M. Zhu; E.K. Rowinsky; E.E. Voest

doi:10.1158/1078-0432.CCR-09-2425

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

B.C. Kuenen, P.O. Witteveen, R. Ruijter, G. Giaccone, A. Dontabhaktuni, F. Fox, T. Katz, H. Youssoufian, J.M. Zhu, E.K. Rowinsky, E.E. Voest

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1915-1923
Journal	Clinical Cancer Research
Volume	16
Issue number	6
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-2425
Publication status	Published - 2010

Access to Document

10.1158/1078-0432.CCR-09-2425

Cite this

Kuenen, B. C., Witteveen, P. O., Ruijter, R., Giaccone, G., Dontabhaktuni, A., Fox, F., Katz, T., Youssoufian, H., Zhu, J. M., Rowinsky, E. K., & Voest, E. E. (2010). A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies. Clinical Cancer Research, 16(6), 1915-1923. https://doi.org/10.1158/1078-0432.CCR-09-2425

@article{1fe2721837974d3185f8521c37b4960c,

title = "A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies",

author = "B.C. Kuenen and P.O. Witteveen and R. Ruijter and G. Giaccone and A. Dontabhaktuni and F. Fox and T. Katz and H. Youssoufian and J.M. Zhu and E.K. Rowinsky and E.E. Voest",

year = "2010",

doi = "10.1158/1078-0432.CCR-09-2425",

language = "English",

volume = "16",

pages = "1915--1923",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

Kuenen, BC, Witteveen, PO, Ruijter, R, Giaccone, G, Dontabhaktuni, A, Fox, F, Katz, T, Youssoufian, H, Zhu, JM, Rowinsky, EK & Voest, EE 2010, 'A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies', Clinical Cancer Research, vol. 16, no. 6, pp. 1915-1923. https://doi.org/10.1158/1078-0432.CCR-09-2425

TY - JOUR

T1 - A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

AU - Kuenen, B.C.

AU - Witteveen, P.O.

AU - Ruijter, R.

AU - Giaccone, G.

AU - Dontabhaktuni, A.

AU - Fox, F.

AU - Katz, T.

AU - Youssoufian, H.

AU - Zhu, J.M.

AU - Rowinsky, E.K.

AU - Voest, E.E.

PY - 2010

Y1 - 2010

U2 - 10.1158/1078-0432.CCR-09-2425

DO - 10.1158/1078-0432.CCR-09-2425

M3 - Article

C2 - 20197484

VL - 16

SP - 1915

EP - 1923

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -